Document Detail


Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction.
MedLine Citation:
PMID:  8418769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Platelets, long recognized for their role in physiological (protective) hemostasis, have been shown conclusively to play an intricate role in both coronary arterial atherogenesis and acute thrombosis. Accordingly, antiplatelet agents have emerged as a prominent feature in treatment strategies designed to prevent and directly confront the progression and thrombotic complications of coronary heart disease in humans. Antiplatelet therapy, used alone or in combination with thrombin antagonists and thrombolytics must be explored with continued enthusiasm to assure growth of this treatment modality.
Authors:
R C Becker
Related Documents :
18685749 - Biventricular apical thrombi demonstrated by contrast-enhanced cardiac mri following an...
6222849 - Methodologic aspects of intracoronary thrombolysis. drugs, dosage and duration.
7605149 - Epidemiology of avoidable delay in the care of patients with acute myocardial infarctio...
10576409 - Establishing equivalence by showing that a specified percentage of the effect of the ac...
9812079 - Prospective echocardiographic analysis of progressive obstruction of the proximal pulmo...
1946929 - Thrombolytic therapy within one hour of the onset of acute myocardial infarction.
10485409 - Two-year assessment by exercise thallium scintigraphy of myocardial revascularization u...
23524949 - Isolation and kv channel recordings in murine atrial and ventricular cardiomyocytes.
18685749 - Biventricular apical thrombi demonstrated by contrast-enhanced cardiac mri following an...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Archives of pathology & laboratory medicine     Volume:  117     ISSN:  0003-9985     ISO Abbreviation:  Arch. Pathol. Lab. Med.     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1993-02-04     Completed Date:  1993-02-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7607091     Medline TA:  Arch Pathol Lab Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  89-96     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester 01655.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Platelets / drug effects,  physiology*
Coronary Disease / blood,  drug therapy*,  prevention & control*
Fibrinolytic Agents / therapeutic use*
Humans
Myocardial Infarction / blood,  drug therapy*,  prevention & control*
Platelet Activation*
Platelet Aggregation
Platelet Aggregation Inhibitors / therapeutic use*
Thrombolytic Therapy*
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?
Next Document:  Oral anticoagulant therapy in the chronic phase of myocardial infarction.